Outpatient chemotherapy decision-making in lung cancer

Japanese Journal of Lung Cancer

Volumn 45, Issue 2, 2005, Pages 105-110

  Hirai, Kei ^a   Tokoro, Akihiro ^b   Naka, Nobuyuki ^c   Ogawara, Mitsumasa ^b   Kawahara, Masaaki ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^c TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Decision making; Outpatient chemotherapy; Trans theoretical model

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IRINOTECAN; METHOTREXATE; NAVELBINE; PACLITAXEL; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG CANCER; MALE; MEDICAL DECISION MAKING; OUTPATIENT;

EID: 20444397452     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.45.105     Document Type: Article

References (8)

1. Outcome working group, ASCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996;14:671-679.
2. Prochaska JO, DiClemente CC. Stages and processes of self-change in smoking: towards an integrative model of change. J Consult Clin Psychol. 1983;51:390-395.
3. Light RJ. Measures of response agreement for qualitative data: some generalizations and alternatives. Psychol Bull. 1971;76:365-377.
4. Stinson CH, Milbrath C, Reidbord SP, et al. Thematic segmentation of psychotherapy transcripts for convergent analyses. Psychotherapy. 1994;31:36-48.
5. Estabrooks C, Goel V, Thiel E, et al. Decision aids: are they worth it? J Health Serv Res Policy. 2001;6:170-182.